Mesna injection is indicated for the prevention of urinary tract toxicity caused by oxazaphosphrine drugs (including ifosfamide, cyclophosphamide, and trophasfamide). Mesna should be used concomitantly with ifosfamide in the chemotherapy of tumors. When high-dose cyclophosphamide (greater than 10 mg/kg) and trophasfamide are used, mesna should be used in combination.
This report contains market size and forecasts of Mesna Injection in global, including the following market information:
Global Mesna Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mesna Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Mesna Injection companies in 2021 (%)
The global Mesna Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
High Dose Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mesna Injection include Baxter, Cadila Healthcare, Mylan, Teva Pharmaceutical, Fresenius Kabi, Hikma Pharmaceuticals, Gland Pharma, Sagent Pharmaceuticals and Athenex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mesna Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mesna Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mesna Injection Market Segment Percentages, by Type, 2021 (%)
High Dose
Low Dose
Global Mesna Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mesna Injection Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Others
Global Mesna Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mesna Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mesna Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mesna Injection revenues share in global market, 2021 (%)
Key companies Mesna Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Mesna Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
Cadila Healthcare
Mylan
Teva Pharmaceutical
Fresenius Kabi
Hikma Pharmaceuticals
Gland Pharma
Sagent Pharmaceuticals
Athenex
Jiangsu Hengrui Medicine
Sinopharm A-Think Pharmaceutical